SynthesisClinical cardiology2022

Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors.

Benjamin M Scirica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.